Top Health Care Stocks
Health care stocks were narrowly mixed Friday, with the NYSE Health Care Index dropping less than 0.1% while shares of health care companies in the S&P 500 were ahead less than 0.1% as a group.
In company news, investors were betting on good news Friday after Portola Pharmaceuticals ( PTLA ) today said it would be discussing interim results from clinical testing of its AndexXa anticoagulant antidote candidate next week at an industry conference in Rome.
The oral presentation is slated for Tuesday at the European Society of Cardiology 2016 Congress and will focus on the drug's ability to reverse anti-blood clotting drugs in patients experiencing major bleeding. AndexXa has been in Phase IIIb/IV testing since January 2015.
PTLA shares were up nearly 1% this afternoon at $19.92 each, earlier reaching a session high of $20.64 a share.
In other sector news,
(+) TGTX, (+2.6%) Confirms Orphan Drug Designation for TG-1101 for the treatment of neuromyelitis optica and neuromyelitis optica spectrum disorder.
(-) ACOR, (-1.3%) Wins Orphan Drug designation for its BTT1023 medication for the treatment of primary sclerosing cholangitis.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.